vx-765 and Brain-Injuries--Traumatic

vx-765 has been researched along with Brain-Injuries--Traumatic* in 1 studies

Other Studies

1 other study(ies) available for vx-765 and Brain-Injuries--Traumatic

ArticleYear
VX765 Attenuates Pyroptosis and HMGB1/TLR4/NF-
    Oxidative medicine and cellular longevity, 2020, Volume: 2020

    Traumatic brain injury (TBI) refers to temporary or permanent damage to brain function caused by penetrating objects or blunt force trauma. TBI activates inflammasome-mediated pathways and other cell death pathways to remove inactive and damaged cells, however, they are also harmful to the central nervous system. The newly discovered cell death pattern termed pyroptosis has become an area of interest. It mainly relies on caspase-1-mediated pathways, leading to cell death.. Our research focus is VX765, a known caspase-1 inhibitor which may offer neuroprotection after the process of TBI. We established a controlled cortical impact (CCI) mouse model and then controlled the degree of pyroptosis in TBI with VX765. The effects of caspase-1 inhibition on inflammatory response, pyroptosis, blood-brain barrier (BBB), apoptosis, and microglia activation, in addition to neurological deficits, were investigated.. In conclusion, VX765 can counteract neurological damage after TBI by reducing pyroptosis and HMGB1/TLR4/NF-

    Topics: Animals; Brain Injuries, Traumatic; Dipeptides; HMGB1 Protein; Male; Mice; NF-kappa B; para-Aminobenzoates; Pyroptosis; Toll-Like Receptor 4; Treatment Outcome

2020